Donate
|
Join/Renew
|
Store
|
Member Directory
|
My SNMMI
Search SNMMI.org
Search SNMMI Learning Center
Value Initiative
|
Physicians
|
Technologists
|
Scientists
|
Residents
|
Healthcare Provider
|
Patients
NEWS & PUBLICATIONS
News and Media
Newsletters
Journals
Books
MEMBERSHIP
Join/Renew
Benefits
Categories
Download a Member Application
Grants, Awards, and Scholarships
Access the Phantom Analysis Toolkit
Membership Directory
Chapters
Centers of Excellence
Councils
Member Spotlight
Women in Nuclear Medicine
SNMMI Fellow
SNMMI-TS Fellow
Council and Center Internships
EDUCATION
Learning Center
2024 Annual Meeting Call for Abstracts
Webinars
MEETINGS & EVENTS
Calendar of Events
Webinars
2023 Fall Therapeutics Conference
2024 Mid-Winter Meeting
2023 Annual Meeting Virtual Sesions
2024 Annual Meeting Call for Abstracts
Nuclear Medicine & Molecular Imaging Week
ADVOCACY
Coding & Reimbursement
Legislative Efforts
Government Relations News
Radiopharmaceutical Supply News
USP 825
Technologist State Issues
Position Statements
FDA PET Drug Manufacturing Q&A
EVIDENCE & QUALITY
Clinical Guidelines and AUC
Quality
Quality and Patient Safety
Dose Optimization
About Quality & Practice
Dosimetry
RESEARCH
Clinical Trials Network
Radiopharmaceutical Therapy Central
Radiopharmaceutical Therapy Centers of Excellence
Preclinical Imaging
Nuclear Medicine Clinical Trial Group, LLC
Research: Learn More
ABOUT SNMMI
Strategic Plan
Bylaws & Procedures
Governance - SNMMI
Governance - SNMMI-TS
History
Grants, Awards, and Scholarships
Career Center
About Nuclear Medicine & Molecular Imaging
International Collaboration
Outreach
Support SNMMI
Contact Us
HOME
>
ADVOCACY
>
Position Statements
In This Section
Coding & Reimbursement
For Hospitals (APCs, IPPS)
For Private Practices (RBRVS)
Coding Q&As
Coding News
Legislative Efforts
Government Relations News
Radiopharmaceutical Supply News
USP 825
Technologist State Issues
State TAG Team
How to be a Grassroots Advocate
Position Statements
FDA PET Drug Manufacturing Q&A
Advertisement
Position Statements
SNMMI-ACNM-ASNC Joint Position Statement on Extravasations and Medical Event Reporting
ASNC-SNMMI Joint Position Statement on the Clinical Indications for Myocardial Perfusion PET
Radiopharmaceutical Reimbursement Policy Statement
Dose Optimization Policy Statement
FDA Radiation Reduction Program Policy Statement
Use of Compounded Radiopharmaceuticals and Adjunct Drug Preparations Policy Statement
Joint Statement on Radioactive Precautions Following Radioactive Iodine Therapy Policy Statement
Beyond-Use Dates (BUD) for Tc-99m Policy Statement
Domestic Isotope Availability Policy Statement
Conditions of Participation/Direct Supervision Policy Statement
Nuclear Medicine Research Funding Policy Statement
RELATED CONTENT
Radiopharmaceutical Supply News
Federal Legislative Efforts
Strategic Plans
Continuing Education Committee (SNMMI-TS)
Committee on Outreach